Pages that link to "Q35750357"
Jump to navigation
Jump to search
The following pages link to TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes (Q35750357):
Displaying 26 items.
- New insights into the biology of tissue factor pathway inhibitor (Q26865048) (← links)
- Biology of tissue factor pathway inhibitor. (Q33585249) (← links)
- Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor (Q33648222) (← links)
- Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region. (Q33706688) (← links)
- Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein (Q36403196) (← links)
- TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity (Q36565141) (← links)
- Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ (Q36852177) (← links)
- Targeting TFPI for hemophilia treatment (Q37108074) (← links)
- Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor (Q37268966) (← links)
- Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation (Q37276726) (← links)
- Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein (Q38316749) (← links)
- Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S. (Q38663583) (← links)
- Vectors and strategies for nonviral cancer gene therapy (Q38694798) (← links)
- Reprogramming cancer cells: overview & current progress. (Q38806067) (← links)
- Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy. (Q38897538) (← links)
- The development of targeted new agents to improve the outcome for children with leukemia (Q38964974) (← links)
- Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. (Q42572887) (← links)
- Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength. (Q49922306) (← links)
- Endothelial cell-anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice (Q50980605) (← links)
- Translational Pharmacokinetic/Pharmacodynamic Characterization and Target-Mediated Drug Disposition Modeling of an Anti-Tissue Factor Pathway Inhibitor Antibody, PF-06741086. (Q52344178) (← links)
- The many domains of TFPI. (Q54195481) (← links)
- Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab. (Q55346403) (← links)
- Anti-tissue factor pathway inhibitor (TFPI) therapy: a novel approach to the treatment of haemophilia (Q57289034) (← links)
- Coagulation Pathways in Neurological Diseases: Multiple Sclerosis (Q64093592) (← links)
- Thrombotic Regulation From the Endothelial Cell Perspectives (Q88792493) (← links)
- Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts (Q89583309) (← links)